Lam Research CEO Timothy Archer Exercises Options, Sells 30,000 Shares

What Happened

• Timothy Archer, President and CEO of Lam Research (LRCX), exercised derivative securities and sold shares on 2026-08-06. The filing shows a 30,000-share exercise at $30.03 (acquired for $900,990) followed the same day by an open-market sale of 30,000 shares at $300.00 for $9,000,000. The filing also reports a 30,000-share derivative conversion listed as disposed at $0.00 (reported value $0).

Key Details

• Transaction date: 2026-08-06 (reported on Form 4 filed 2026-08-07) — timely filing.
• Exercise: 30,000 shares at $30.03 = $900,990 (acquired).
• Sale: 30,000 shares at $300.00 = $9,000,000 (disposed).
• Additional derivative line: 30,000 shares shown as exercised/converted with $0.00 value and disposed for $0 (per filing).
• Shares owned after transaction: not specified in the provided filing excerpt.
• Footnotes: F1 — transaction effected under a Rule 10b5-1 trading plan adopted Feb 24, 2026; F2 — reported amount includes shares subject to unvested restricted stock units; F3 — related stock options vesting schedule noted (exercisable in three equal installments on 03/02/2021, 03/02/2022, 03/02/2023).

Context

• This is a sale of shares following an option exercise; same-day exercise-plus-sale is commonly a cashless exercise and sale to realize value, but the filing should be read for exact settlement details. The 10b5-1 footnote indicates the sale was pre-planned rather than a discretionary one-off trade. Because this is an executive sale (not a purchase), it is generally considered routine insider liquidity rather than a clear bullish signal.